The Cigna Group (CI)
Official siteHEALTHCARE • HEALTHCARE PLANS • NYSE
Market Cap: $78.26B
Last updated: Nov 17, 2026 at 4:29 PM ET
The Cigna Group (CI) Statistics
The Cigna Group (CI) has a market cap of $78.26B and an enterprise value of $147.09B. Its net debt of $68.83B equals 87.95% of its market cap. Its trailing P/E of 9.3x is below its 10-year median of 12.0x.
Total Valuation
Enterprise value is 87.95% above the market cap, as debt exceeds cash.
| Market Cap | $78.26B |
|---|---|
| Enterprise Value | $147.09B |
| Latest price (Nov 17, 2026) | $294.09 |
Key Dates
The next earnings report is expected on Feb 3, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 3, 2026.
| Next Earnings Date | Feb 3, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Next Ex-Dividend Date | Dec 3, 2026 |
| Next Payment Date | Dec 17, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.3x and 1.8x. Its year-end P/E ranged from 9.2x to 19.4x from 2016 to 2025.
| P/E Ratio | 9.3x |
|---|---|
| Forward P/E | 9.3x |
| P/S Ratio | 0.3x |
| Forward P/S | 0.3x |
| P/B Ratio | 1.8x |
| P/FCF Ratio | 9.4x |
| P/OCF Ratio | 8.3x |
| PEG Ratio | 1.0 |
Enterprise Valuation
Counting debt and cash, the company is valued at 11.5x EBITDA and 17.7x free cash flow.
| EV / Earnings | 21.9x |
|---|---|
| EV / Sales | 0.5x |
| EV / EBITDA | 11.5x |
| EV / EBIT | 14.9x |
| EV / FCF | 17.7x |
Price Statistics
The stock is up 10.28% over 52 weeks and trades 2.02% above its 50-day average.
| Beta (1Y) | 0.08 |
|---|---|
| 52-Week Change | +10.28% |
| 1-Month Change | -1.48% |
| 3-Month Change | +6.60% |
| 6-Month Change | +2.10% |
| 5-Year Change | +39.61% |
| 10-Year Change | +150.97% |
| Total Return (1Y) | +12.60% |
| Total Return (3Y CAGR) | +2.56% |
| Total Return (5Y CAGR) | +7.61% |
| Return vs SPY (1Y) | -2.47% |
| Max Drawdown (1Y) | -12.31% |
| Max Drawdown (3Y) | -32.86% |
| Sharpe Ratio (1Y) | 0.33 |
| Correlation with SPY (1Y) | 0.04 |
| 50-Day Average | $288.26 |
| 200-Day Average | $281.47 |
| 52-Week Range | $253.96 to $318.05 |
| RSI (14 Days) | 48.6 |
| Average Volume (20 Days) | 1.69M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Total debt is 1.73x shareholder equity.
| Debt / Equity | 1.73x |
|---|---|
| Debt / EBITDA | 5.89x |
| Debt / FCF | 9.08x |
Returns and Efficiency
Return on invested capital is 6.61% over the last 12 months, against a 5-year average of 7.26%.
| Return on Equity (ROE) | 15.46% |
|---|---|
| Return on Assets (ROA) | 4.26% |
| Return on Invested Capital (ROIC) | 6.61% |
| ROE (5Y Average) | 12.52% |
| ROA (5Y Average) | 3.63% |
| ROIC (5Y Average) | 7.26% |
| Asset Turnover | 1.82x |
Taxes
Income tax took 20.55% of pretax income over the last 12 months.
| Income Tax (TTM) | $1.74B |
|---|---|
| Effective Tax Rate | 20.55% |
Scores
CI has a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 6 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue of $286.39B over the last 12 months is up 7.43% from the 12 months before.
| Revenue | $286.39B |
|---|---|
| Revenue Growth (YoY) | +7.43% |
| Pretax Income | $8.44B |
| Net Income | $6.71B |
| EBITDA | $12.74B |
| EBIT | $9.85B |
| Reported EPS (TTM) | $31.63 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 27.52% of the $157.64B in total assets.
| Cash and Equivalents | $6.19B |
|---|---|
| Total Debt | $75.01B |
| Net Debt | $68.83B |
| Net Debt Per Share | $261.20 |
| Shareholder Equity | $43.38B |
| Book Value Per Share | $164.64 |
| Tangible Book Value | -$28.91B |
| Total Assets | $157.64B |
| Total Liabilities | $113.92B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $1.16B of capital spending, operating cash flow left $8.27B of free cash flow.
| Operating Cash Flow | $9.43B |
|---|---|
| Capital Expenditures | $1.16B |
| Free Cash Flow | $8.27B |
| FCF Per Share | $31.28 |
| Depreciation and Amortization | $2.89B |
| Dividends Paid | $1.63B |
| Share Repurchases | $1.53B |
Trailing 12 months through Sep 30, 2026.
Margins
| Pretax Margin | 2.95% |
|---|---|
| Net Margin | 2.34% |
| EBITDA Margin | 4.45% |
| EBIT Margin | 3.44% |
| FCF Margin | 2.89% |
| Gross Margin (5Y Average) | 11.84% |
| Operating Margin (5Y Average) | 4.16% |
| Net Margin (5Y Average) | 2.69% |
Growth
Revenue grew 14.80% a year over 3 years, and EPS 8.72% a year.
| Revenue Growth (3Y CAGR) | +14.80% |
|---|---|
| Revenue Growth (5Y CAGR) | +10.81% |
| EPS Growth (3Y CAGR) | +8.72% |
| EPS Growth (5Y CAGR) | +10.14% |
| FCF Growth (3Y CAGR) | +4.45% |
| FCF Growth (5Y CAGR) | -1.95% |
| Operating Income Growth (3Y CAGR) | +2.61% |
| Book Value Per Share Growth (2Y CAGR) | -0.02% |
Dividends and Yields
CI pays out 17.30% of earnings as dividends.
| Dividend Per Share (Annual) | $6.24 |
|---|---|
| Dividend Yield | 2.12% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +10.47% |
| Dividend Growth (5Y CAGR) | +172.77% |
| Payout Ratio | 17.30% |
| FCF Payout Ratio | 19.74% |
| Earnings Yield | 10.75% |
| FCF Yield | 10.67% |
| Buyback Yield | 1.70% |
| Shareholder Yield | 3.80% |
Stock Splits
The last split was a 3-for-1 forward split on Jun 5, 2007.
| Last Split Date | Jun 5, 2007 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 3:1 |
Peer Position
Against 12 similar companies, CI has the lowest P/E and the 9th highest P/S.
P/E RatioPeer median 21.2x
P/S RatioPeer median 0.4x
ROICPeer median 9.34%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +9.61%
Dividend YieldPeer median 0.68%
| P/E Ratio | 9.3x vs 21.2x median |
|---|---|
| P/S Ratio | 0.3x vs 0.4x median |
| ROIC | 6.61% vs 9.34% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +7.43% vs +9.61% median |
| Dividend Yield | 2.12% vs 0.68% median |
Analyst Forecast
Consensus estimates put revenue growth at 4.31% and EPS growth at 5.56% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +4.31% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +5.56% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CI
What is CI's market cap?
The Cigna Group has a market cap of $78.26B. Its enterprise value, which adds debt and subtracts cash, is $147.09B.
What is CI's P/E ratio?
The Cigna Group has a trailing P/E ratio of 9.3x and a forward P/E of 9.3x.
How many shares of CI are outstanding?
The Cigna Group has 263.50M shares outstanding. The count is down 1.36% from a year earlier.
Does CI pay a dividend?
Yes. The Cigna Group pays $6.24 a share a year, a dividend yield of 2.12%.
How much debt does CI have?
The Cigna Group has $75.01B of total debt and $6.19B of cash and equivalents, a net debt position of $68.83B.
CI pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors